semaglutide bs tirzepatide vs. Semaglutide: Which Weight Loss Medication is Right for You? Semaglutide, tirzepatide recommended as first-line

GLP-1s support your pancreas in releasing just the right amount of insulin when you need it, and they help your cells become more sensitive to that insulin

The Verdict: If you are looking for abs or vanished wrinkles in Week 3, you are looking in the wrong place

Contrastingly, GLP1 antagonist sales in 2023 showcase a more diversified landscape, with therapeutics such as Ozempic, Trulicity, and Mounjaro driving 71 per cent of the sales. Looking ahead, the GLP1 agonist market is poised for robust growth, anticipating a 19.2 per cent compound annual growth rate (CAGR) from 2023 to 2029, reaching a substantial market size of $105 billion in 2029

The episode is interactive, with McCall addressing questions submitted by listeners via Instagram, offering a wealth of insights and personal experiences